(Q41897949)

13 October 2017

Controlled trial of gamma linolenic acid in Duke's C colorectal cancer (English)

1 reference

13 October 2017

1 reference

McIllmurray MB

1

1 reference

13 October 2017

Turkie W

series ordinal

2

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 May 1987

1 reference

13 October 2017

1 reference

13 October 2017

294

1 reference

13 October 2017

1260

1 reference

13 October 2017

6582

1 reference

The reversibility of cancer: evidence that malignancy in human hepatoma cells is gamma-linolenic acid deficiency-dependent

13 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1246429

The reversibility of cancer: the relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1.

5 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1246429

The reversibility of cancer: evidence that malignancy in melanoma cells is gamma-linolenic acid deficiency-dependent.

5 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1246429

The effect of gamma-linolenic acid on the growth of human osteogenic sarcoma and oesophageal carcinoma cells in culture

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3036291

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

13 October 2017

1 reference